search
Back to results

Adherence and Acceptability of a Remote, Home-based, Pre-surgery Programme for Patients Undergoing Abdominal Aortic Aneurysm Surgery

Primary Purpose

Aortic Aneurysm, Abdominal

Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Prehabilitation
Sponsored by
Imperial College Healthcare NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Aortic Aneurysm, Abdominal focused on measuring AAA, pre-conditioning, frailty

Eligibility Criteria

55 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria

  • Adults (aged 55 years and over) who have been diagnosed with an AAA and are scheduled to undergo EVAR or open surgery (with a wait time of at least 6-weeks for surgery).
  • Patients with an AAA with a diameter of 5.5cm to 7cm
  • Able to write, understand and communicate in English
  • Willing and able to participate in a virtual prehabilitation programme

Exclusion Criteria:

  • Thoraco-Abdominal Aneurysms
  • Connective tissue Vascular Disorder
  • Symptomatic aneurysms
  • Previous Aortic intervention
  • Absolute contraindication to exercise
  • Inability or unwillingness to participate in the trial
  • Infrarenal AAA diameter exceeding 7.0cm
  • Emergency AAA repair
  • BMI below 20 kg/m2 or above 45 kg/m2

Sites / Locations

  • Imperial College LondonRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Prehabilitation group

Arm Description

This arm will be subject to at least 6 weeks of a tailored prehabilitation programme

Outcomes

Primary Outcome Measures

Feasibility of screening and recruitment
The number of participants referred at each site will be captured The number of participants eligible for screening at each site will be captured The number of participants enrolled at each site will be captured Reasons for non-participation will be captured
Feasibility of measurement tools:
Time taken to complete the questionnaires at each time-point The ratio of missing data from questionnaires Follow-up response rates
Adherence
Number of sessions attended The proportion of participants who complete' the 6-week programme
Acceptability of the prehabilitation programme (Patient satisfaction)
Patient satisfaction will be measured using questionnaires Reasons for drop-out will be captured.

Secondary Outcome Measures

In-Hospital Complication Rate
- Composite of Cardiac, Respiratory, Renal, Haemorrhage, Limb Ischaemia and Cerebral Complications, as defined by National Vascular Registry
30-day(After surgery) Composite Outcome
Incidence of Mortality Incidence of complications
Length of stay and readmission rates (30 days post-surgery)
Reintervention, or areadmission related to repair or other complications
Change in 6-minute walk test (6-MWT) at end of programme, Discharge, 6-weeks (Post discharge) and 3 months (Post Discharge)
To measure the change of patient physical function
Change in health-related quality of life scores (using the EuroQol five-dimensional questionnaire [EQ-5D] and visual analogue scale [EQ-VAS]) at end of programme, Discharge, 6-weeks (Post discharge) and 3 months (Post Discharge)
Participants quality of life measure throughout the study
Post-Operative Morbidity score (POMS)
To measure post operative complications and it's impact on participants
Change in aneurysm specific quality of life scores at end of programme, Discharge, 6-weeks (Post discharge) and 3 months (Post Discharge)
Participants quality of life measure related to aneurysm repair throughout the study
Change in Hospital Anxiety and Depression Score (HADS) end of programme, Discharge, 6-weeks (Post discharge) and 3 months (Post Discharge)
Participants anxiety and depression score change throughout the study 0-7 (Normal) 8-10 (Mild) 11-15 (Moderate) 16-21 (Severe)
Change in cigarettes usage per day
Difference in cigarettes usage at different phases of the study
Change in weight (in kg) end of programme, Discharge, 6-weeks (Post discharge) and 3 months (Post Discharge)
Measure weight change

Full Information

First Posted
March 4, 2021
Last Updated
May 5, 2022
Sponsor
Imperial College Healthcare NHS Trust
Collaborators
Cambridge University Hospitals NHS Foundation Trust, Mid and South Essex NHS Foundation Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT04792411
Brief Title
Adherence and Acceptability of a Remote, Home-based, Pre-surgery Programme for Patients Undergoing Abdominal Aortic Aneurysm Surgery
Official Title
Multi-centre, Pilot Study Evaluating the Feasibility, Acceptability, and Short-term Outcomes of a Tailored, Virtual, Home-based, Multicomponent Prehabilitation Programme in Patients Undergoing Abdominal Aortic Aneurysms (AAA) Repair.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 1, 2021 (Actual)
Primary Completion Date
September 1, 2022 (Anticipated)
Study Completion Date
December 1, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Imperial College Healthcare NHS Trust
Collaborators
Cambridge University Hospitals NHS Foundation Trust, Mid and South Essex NHS Foundation Trust

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Design A multi-centre pilot study investigating the acceptability and adherence of a prehabilitation on patients requiring abdominal aortic aneurysm repair. Setting 3 NHS Hospital Vascular Surgery Clinics in the UK. Imperial College Healthcare NHS Trust Cambridge University Hospitals NHS Trust Mid and South Essex NHS Trust Patient Population Patients referred to secondary/tertiary vascular clinic for the repair of asymptomatic infrarenal Aneurysm Intervention: Baseline (conducted face-to-face): After providing written informed consent, participants will be provided with information about the prehabilitation programme. The following data will also be collected: baseline demographic characteristics (including age, sex and ethnicity), body mass index (BMI), medical history (including time since diagnosis), current medication, aneurysm diameter, health-related quality of life (EQ-5D-5L and EQ-VAS), smoking status and psychological wellbeing (using the Hospital Anxiety and Depression Scale; HADS) and Frailty assessments( QMortality Index, Electronic Frailty Index, Rockall score). Participants will also complete a 6-minute walking test(6MWT).
Detailed Description
Weeks 1 to 5 (conducted remotely via telephone, email or completion of an online survey): The programme has been developed with experts in the field of sports therapy, physiotherapy and biomechanics, based on robust literature in other fields. The course plan is to start with 3 sessions every week for 6 weeks where participants would complete a tailored home exercise programme or until the expected surgical intervention. In the first week of this programme, the patient will receive three sessions with a total of 150 minutes of exercise according to UK Chief Medical Officers' Physical Activity Guidelines. After each week, we will assess patient tolerance to the exercise regime using Borg scale. The researchers will either increase or decrease exercise intensity according to their feedback. The study will also be assessing patients' preference for how and when they would like to exercise. End of Programme (conducted remotely via telephone, email or completion of an online survey): Participants will be contacted by a member of the study team for the reassessment of health-related quality of life, psychological wellbeing and smoking status. Participants will also be required to provide their self-reported weight. On admission for surgery, they will be assessed for frailty using frailty score assessments Post - Operative Morbidity score(POMS) will be assessed during admission ( Day1, Day 3, Day 5, Day 7, etc) after surgery. Discharge: (conducted either remotely or face to face): Participants will complete a reassessment of health-related quality of life, disease-specific quality of life, psychological wellbeing and smoking status. Participants will also complete the 6-MWT. 6 weeks post-surgery (conducted remotely or face-to-face): Participants will complete a reassessment of health-related quality of life, disease-specific quality of life, psychological wellbeing and smoking status. Participants will also complete the 6-MWT. 90-days post-surgery (conducted remotely or face-to-face): Participants will complete reassessment of health-related quality of life, disease-specific quality of life, psychological wellbeing and smoking status. Participants will also complete the 6-MWT. Participants will also complete a frailty assessment score (Rockall) Treatments Standard national and local practice will be followed for the repair of infra-renal aortic aneurysm. Patients will receive any type of repair as decided by the local Vascular Multi-Disciplinary Team. Primary Outcome Prehabilitation Programme compliance, attendance and acceptability. Secondary Outcomes In-Hospital Complication Rate - Composite of Cardiac, Respiratory, Renal, Haemorrhage, Limb Ischaemia and Cerebral Complications, as defined by National Vascular Registry Length of stay and readmission rates (30 days post-surgery) 30-day Composite Outcome: Death and Defined complication (Cardiac, respiratory, haemorrhage, limb ischaemia, renal failure) Change in 6-minute walk test (6-MWT) at end of programme, Discharge, 6-weeks (Post discharge) and 3 months (Post Discharge) Change in health-related quality of life scores (using the EuroQol five-dimensional questionnaire [EQ-5D] and visual analogue scale [EQ-VAS]) at end of programme, Discharge, 6-weeks (Post discharge) and 3 months (Post Discharge) Post-Operative Morbidity score (POMS) Change in aneurysm specific quality of life scores at end of programme, Discharge, 6-weeks (Post discharge) and 3 months (Post Discharge) Change in Hospital Anxiety and Depression Score (HADS) at 6-weeks post enrolment and 30 and 90-days post-surgery Reduction in cigarettes per day at 6-weeks post enrolment and 30 and 90-days post-surgery Change in weight (in kg) 6-weeks post enrolment and 30 and 90-days post-surgery

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aortic Aneurysm, Abdominal
Keywords
AAA, pre-conditioning, frailty

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Prehabilitation group
Arm Type
Experimental
Arm Description
This arm will be subject to at least 6 weeks of a tailored prehabilitation programme
Intervention Type
Behavioral
Intervention Name(s)
Prehabilitation
Intervention Description
Multimodal, tailored prehabilitation programme
Primary Outcome Measure Information:
Title
Feasibility of screening and recruitment
Description
The number of participants referred at each site will be captured The number of participants eligible for screening at each site will be captured The number of participants enrolled at each site will be captured Reasons for non-participation will be captured
Time Frame
18 months
Title
Feasibility of measurement tools:
Description
Time taken to complete the questionnaires at each time-point The ratio of missing data from questionnaires Follow-up response rates
Time Frame
18 months
Title
Adherence
Description
Number of sessions attended The proportion of participants who complete' the 6-week programme
Time Frame
at least 6 weeks ( Duration of the programme)
Title
Acceptability of the prehabilitation programme (Patient satisfaction)
Description
Patient satisfaction will be measured using questionnaires Reasons for drop-out will be captured.
Time Frame
18 months
Secondary Outcome Measure Information:
Title
In-Hospital Complication Rate
Description
- Composite of Cardiac, Respiratory, Renal, Haemorrhage, Limb Ischaemia and Cerebral Complications, as defined by National Vascular Registry
Time Frame
Immediately after the surgery
Title
30-day(After surgery) Composite Outcome
Description
Incidence of Mortality Incidence of complications
Time Frame
30 days
Title
Length of stay and readmission rates (30 days post-surgery)
Description
Reintervention, or areadmission related to repair or other complications
Time Frame
30 days
Title
Change in 6-minute walk test (6-MWT) at end of programme, Discharge, 6-weeks (Post discharge) and 3 months (Post Discharge)
Description
To measure the change of patient physical function
Time Frame
6 weeks, 3 months
Title
Change in health-related quality of life scores (using the EuroQol five-dimensional questionnaire [EQ-5D] and visual analogue scale [EQ-VAS]) at end of programme, Discharge, 6-weeks (Post discharge) and 3 months (Post Discharge)
Description
Participants quality of life measure throughout the study
Time Frame
6 weeks, 3 months
Title
Post-Operative Morbidity score (POMS)
Description
To measure post operative complications and it's impact on participants
Time Frame
Immediately after surgery
Title
Change in aneurysm specific quality of life scores at end of programme, Discharge, 6-weeks (Post discharge) and 3 months (Post Discharge)
Description
Participants quality of life measure related to aneurysm repair throughout the study
Time Frame
6 weeks, 3 months
Title
Change in Hospital Anxiety and Depression Score (HADS) end of programme, Discharge, 6-weeks (Post discharge) and 3 months (Post Discharge)
Description
Participants anxiety and depression score change throughout the study 0-7 (Normal) 8-10 (Mild) 11-15 (Moderate) 16-21 (Severe)
Time Frame
6 weeks, 3 months
Title
Change in cigarettes usage per day
Description
Difference in cigarettes usage at different phases of the study
Time Frame
6 weeks, 3 months
Title
Change in weight (in kg) end of programme, Discharge, 6-weeks (Post discharge) and 3 months (Post Discharge)
Description
Measure weight change
Time Frame
6 weeks, 3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria Adults (aged 55 years and over) who have been diagnosed with an AAA and are scheduled to undergo EVAR or open surgery (with a wait time of at least 6-weeks for surgery). Patients with an AAA with a diameter of 5.5cm to 7cm Able to write, understand and communicate in English Willing and able to participate in a virtual prehabilitation programme Exclusion Criteria: Thoraco-Abdominal Aneurysms Connective tissue Vascular Disorder Symptomatic aneurysms Previous Aortic intervention Absolute contraindication to exercise Inability or unwillingness to participate in the trial Infrarenal AAA diameter exceeding 7.0cm Emergency AAA repair BMI below 20 kg/m2 or above 45 kg/m2
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Majd Rawashdeh, MBBS
Phone
02033117335
Email
majd.rawashdeh12@imperial.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alun Davies
Organizational Affiliation
Imperial College NHS Trust
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Tristan Lane
Organizational Affiliation
Cambridge University Hospitals NHS Trust
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ankur Thapar
Organizational Affiliation
Mid and South Essex NHS Foundation Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
Imperial College London
City
London
ZIP/Postal Code
W68RF
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Majd Rawshdeh
Email
mr2812@ic.ac.uk

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Adherence and Acceptability of a Remote, Home-based, Pre-surgery Programme for Patients Undergoing Abdominal Aortic Aneurysm Surgery

We'll reach out to this number within 24 hrs